| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
218,850,000 |
| Market
Cap: |
39.94(B) |
| Last
Volume: |
90,505,923 |
Avg
Vol: |
10,707,238 |
| 52
Week Range: |
$182.5 - $182.5 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Goff Brian |
EVP & Chief Commercial Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,894 |
30,613 |
|
- |
|
| Hantson Ludwig |
CEO |
• • – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
95,253 |
131,425 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,989 |
49,199 |
|
- |
|
| Wagner Heidi L |
SVP, Global Government Affairs |
• – – |
2018-02-05 |
4 |
S |
$117.26 |
$76,805 |
D/D |
(655) |
32,635 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2018-02-05 |
4 |
S |
$117.26 |
$248,474 |
D/D |
(2,119) |
20,210 |
|
- |
|
| Moriarty John B |
EVP & General Counsel |
• – – |
2018-02-05 |
4 |
S |
$117.26 |
$147,865 |
D/D |
(1,261) |
49,911 |
|
- |
|
| Hantson Ludwig |
CEO |
• • – |
2018-01-02 |
4 |
S |
$121.63 |
$310,521 |
D/D |
(2,553) |
36,172 |
|
- |
|
| Coughlin Christopher J |
Director |
– • – |
2017-12-05 |
4 |
A |
$112.75 |
$1,127,500 |
D/D |
10,000 |
16,333 |
|
- |
|
| Friedman Paul A |
Director |
– • – |
2017-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,977 |
1,977 |
|
- |
|
| Nader Francois |
Director |
– • – |
2017-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,977 |
1,977 |
|
- |
|
| Wagner Heidi L |
SVP, Global Government Affairs |
• – – |
2017-10-02 |
4 |
S |
$140.00 |
$16,800 |
D/D |
(120) |
33,290 |
|
- |
|
| Veneman Ann M |
Director |
– • – |
2017-09-05 |
4 |
AS |
$145.81 |
$121,751 |
D/D |
(835) |
5,480 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2017-09-05 |
4 |
AS |
$145.64 |
$549,381 |
D/D |
(3,763) |
22,329 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2017-08-31 |
4 |
AS |
$142.00 |
$86,904 |
D/D |
(612) |
26,092 |
|
- |
|
| Oneill Julie |
EVP. Global Operations |
• – – |
2017-08-28 |
4 |
AS |
$140.00 |
$1,562,400 |
D/D |
(11,160) |
26,704 |
|
- |
|
| Veneman Ann M |
Director |
– • – |
2017-07-31 |
4 |
AS |
$137.74 |
$96,418 |
D/D |
(700) |
6,315 |
|
- |
|
| Clancy Paul J |
EVP, Chief Financial Officer |
• – – |
2017-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
46,865 |
46,865 |
|
- |
|
| Baker Brothers Life Sciences Lp |
Director |
– • – |
2017-06-15 |
4 |
B |
$116.54 |
$77,012,491 |
I/I |
656,387 |
980,146 |
2.1 |
- |
|
| Parven Alvin S |
Director |
– • – |
2017-06-15 |
4 |
S |
$116.78 |
$97,511 |
D/D |
(835) |
7,568 |
|
- |
|
| Coughlin Christopher J |
Director |
– • – |
2017-06-15 |
4 |
B |
$117.10 |
$234,200 |
D/D |
2,000 |
6,333 |
2.39 |
- |
|
| Hantson Ludwig |
CEO |
• • – |
2017-06-14 |
4 |
B |
$116.72 |
$1,167,200 |
D/D |
10,000 |
38,725 |
2.81 |
- |
|
| Baker Brothers Life Sciences Lp |
Director |
– • – |
2017-06-14 |
4 |
B |
$118.00 |
$518,256 |
I/I |
4,392 |
7,321,850 |
2.1 |
- |
|
| Baker Brothers Life Sciences Lp |
Director |
– • – |
2017-06-14 |
4 |
B |
$114.33 |
$156,915,444 |
I/I |
1,348,955 |
7,317,906 |
2.1 |
- |
|
| Franchini Indrani Lall |
EVP, Chief Compliance Officer |
• – – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,582 |
12,582 |
|
- |
|
| Law Anne-Marie |
EVP and CHRO |
• – – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,968 |
0 |
|
- |
|
1501 Records found
|
|
Page 9 of 61 |
|
|
